• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.tau 病理学:预测诊断、靶向预防和个性化医学以及先进研究在医学实践中的应用。
EPMA J. 2010 Jun;1(2):305-16. doi: 10.1007/s13167-010-0029-y. Epub 2010 Jun 12.
2
[Neuropathology of tauopathy].[tau蛋白病的神经病理学]
Brain Nerve. 2013 Dec;65(12):1445-58.
3
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.tau 相互作用蛋白:深入了解 tau 在健康和疾病中的作用。
Adv Exp Med Biol. 2019;1184:145-166. doi: 10.1007/978-981-32-9358-8_13.
4
Tau pathology and future therapeutics.tau 病理学与未来治疗策略
Curr Alzheimer Res. 2010 Dec;7(8):685-96. doi: 10.2174/156720510793611628.
5
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.糖原合酶激酶-3与阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性中的神经元和胶质细胞过度磷酸化tau蛋白沉积有关。
Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13.
6
Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性患者大脑中tau蛋白微管结合区域的不同免疫反应性及其分子基础。
Acta Neuropathol. 2003 May;105(5):489-98. doi: 10.1007/s00401-003-0671-8. Epub 2003 Feb 8.
7
Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration.在 Tau 介导的神经退行性疾病中少有人探索的领域:少突胶质细胞功能障碍。
Cells. 2024 Jun 27;13(13):1112. doi: 10.3390/cells13131112.
8
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.使用新型构象选择性 Tau 抗体通过免疫组织化学检测 AD 和非 AD Tau 病中的 AD 特异性 Tau 病理学。
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010.
9
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
10
Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy.阿尔茨海默病和进行性核上性麻痹中的tau蛋白免疫疗法。
Int Immunopharmacol. 2022 Dec;113(Pt B):109445. doi: 10.1016/j.intimp.2022.109445. Epub 2022 Nov 18.

引用本文的文献

1
Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer's Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways.通过氧化磷酸化和逆行内源性大麻素信号通路鉴定阿尔茨海默病相关的线粒体复合物的分子特征。
Oxid Med Cell Longev. 2022 Apr 5;2022:9565545. doi: 10.1155/2022/9565545. eCollection 2022.
2
Integrative genomic analysis of PPP3R1 in Alzheimer's disease: a potential biomarker for predictive, preventive, and personalized medical approach.阿尔茨海默病中PPP3R1的综合基因组分析:一种用于预测、预防和个性化医疗方法的潜在生物标志物。
EPMA J. 2021 Nov 15;12(4):647-658. doi: 10.1007/s13167-021-00261-2. eCollection 2021 Dec.
3
Tau Diagnostics and Clinical Studies.tau 诊断和临床研究。
J Mol Neurosci. 2017 Oct;63(2):123-130. doi: 10.1007/s12031-017-0983-0.
4
Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.阿尔茨海默病的特定蛋白质生物标志物模式:诊断方法正在改进。
EPMA J. 2017 Sep 4;8(3):255-259. doi: 10.1007/s13167-017-0110-x. eCollection 2017 Sep.
5
Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.微管功能的性差异:新型鼻内微管靶向 SKIP 可使轴突运输正常化并增强记忆。
Mol Psychiatry. 2016 Oct;21(10):1467-76. doi: 10.1038/mp.2015.208. Epub 2016 Jan 19.
6
Neurodegeneration: accelerated ageing or inadequate healthcare?神经退行性病变:加速老化还是医疗保健不足?
EPMA J. 2010 Jun;1(2):211-5. doi: 10.1007/s13167-010-0030-5. Epub 2010 Jun 29.

本文引用的文献

1
Tau pathology and future therapeutics.tau 病理学与未来治疗策略
Curr Alzheimer Res. 2010 Dec;7(8):685-96. doi: 10.2174/156720510793611628.
2
Tubulin in the nervous system.神经系统中的微管蛋白。
Neurochem Int. 1982;4(2-3):101-20. doi: 10.1016/0197-0186(82)90003-1.
3
NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.NAP(达文西肽)增强了 STOP 杂合子小鼠的认知行为——一种精神分裂症的微管缺陷模型。
Peptides. 2010 Jul;31(7):1368-73. doi: 10.1016/j.peptides.2010.04.011. Epub 2010 Apr 22.
4
Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing.缺氧缺血和蛋白酶体功能障碍通过抑制外显子 10 剪接改变 tau 异构体比例。
J Neurochem. 2010 Jul;114(1):160-70. doi: 10.1111/j.1471-4159.2010.06732.x. Epub 2010 Apr 3.
5
PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.PP2A 通过直接调节 tau 磷酸化和间接激活 GSK-3β来调节 tau 磷酸化。
J Alzheimers Dis. 2010;19(4):1221-9. doi: 10.3233/JAD-2010-1317.
6
Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells.转移性乳腺癌肿瘤表达增加的 tau,促进微刺的形成和脱落的乳腺癌肿瘤细胞的重新附着。
Oncogene. 2010 Jun 3;29(22):3217-27. doi: 10.1038/onc.2010.68. Epub 2010 Mar 15.
7
'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.在诱导型tau 病小鼠模型中,鼠和人 tau 聚集物的“类朊病毒样”传播。
Neurodegener Dis. 2010;7(1-3):28-31. doi: 10.1159/000283479. Epub 2010 Feb 13.
8
The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.tau 基因(MAPT)的 H1 单倍型与轻度认知障碍有关。
J Alzheimers Dis. 2010;19(3):909-14. doi: 10.3233/JAD-2010-1285.
9
CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.脑脊液生物标志物在轻度认知障碍和阿尔茨海默病中预测脑和临床变化的应用。
J Neurosci. 2010 Feb 10;30(6):2088-101. doi: 10.1523/JNEUROSCI.3785-09.2010.
10
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.健康老年人纵向脑脊液生物标志物与认知衰退的相关性
Arch Neurol. 2010 Feb;67(2):217-23. doi: 10.1001/archneurol.2009.316.

tau 病理学:预测诊断、靶向预防和个性化医学以及先进研究在医学实践中的应用。

Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.

机构信息

Department of Human Molecular Genetics and Biochemistry The Lily and Avraham Gildor Chair for the Investigation of Growth Factors and The Adams Super Center for Brain Studies Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel.

出版信息

EPMA J. 2010 Jun;1(2):305-16. doi: 10.1007/s13167-010-0029-y. Epub 2010 Jun 12.

DOI:10.1007/s13167-010-0029-y
PMID:23199066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3405325/
Abstract

Microtubules are key cytoskeletal elements found in all eukaryotic cells. The microtubule shaft is composed of the heterodimer protein, tubulin and decorated with multiple microtubule associated protein, regulating microtubule function. Tau (tubulin associated unit) or MAPT (microtubule associated protein tau), among the first microtubule associated proteins to be identified, was implicated in microtubule initiation as well as assembly, with increased expression in neurons and specific association with axonal microtubules. Alzheimer's disease (AD) is the most prevalent tauopathy, exhibiting tau-neurofibrillary tangles associated with cognitive dysfunction. AD is also characterized by β-amyloid plaques. An abundance of tau inclusions, in the absence of β-amyloid deposits, can be found in Pick's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other diseases, collectively described as tauopathies. The increase in tau pathology in AD correlates with the associated cognitive decline. The current manuscript touches on the variability as well as common denominators of the various tau pathologies coupled to new approaches/current innovation in treatment of tauopathies in favor of advanced technologies in predictive diagnostics, targeted preventive and personalized medicine (PPPM).

摘要

微管是所有真核细胞中关键的细胞骨架元件。微管轴由异二聚体蛋白微管蛋白组成,并被多种微管相关蛋白所修饰,调节微管功能。Tau(微管相关蛋白 Tau)或 MAPT(微管相关蛋白 Tau)是最早被鉴定的微管相关蛋白之一,与微管的起始和组装有关,在神经元中表达增加,并与轴突微管特异性结合。阿尔茨海默病(AD)是最常见的 Tau 病,表现为与认知功能障碍相关的 Tau 神经原纤维缠结。AD 还以β-淀粉样斑块为特征。在 Pick 病、进行性核上性麻痹(PSP)、皮质基底节变性(CBD)和其他疾病中,可以发现大量 Tau 包含物,而没有β-淀粉样沉积物,这些疾病统称为 Tau 病。AD 中 Tau 病理学的增加与相关的认知能力下降有关。本文档涉及到各种 Tau 病理学的可变性以及共同特征,以及 Tau 病治疗的新方法/当前创新,以支持预测性诊断、靶向预防和个性化医学(PPPM)的先进技术。